Nath Bio-Genes closes trading window ahead of financial results

Nath Bio-Genes (India) Ltd. announced the closure of its trading window for dealing in company securities, effective from Thursday, January 1, 2026. This is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal Code of Conduct for Prevention of Insider Trading.

The window will remain closed until 48 hours after the declaration of the unaudited financial results for the quarter and nine months ending December 31, 2025. The specific date for the board meeting to declare these results will be communicated separately. This measure is a standard procedure to prevent insider trading ahead of significant financial disclosures. The announcement was made by amol gupta, chief financial officer, on December 27, 2025.